Financials Global Health Limited

Equities

MEDANTA

INE474Q01031

Healthcare Facilities & Services

End-of-day quote NSE India S.E. 06:00:00 2024-06-04 pm EDT 5-day change 1st Jan Change
1,122 INR +4.23% Intraday chart for Global Health Limited -5.47% +17.02%

Valuation

Fiscal Period: March 2023 2024 2025 2026
Capitalization 1 141,325 301,373 - -
Enterprise Value (EV) 1 141,325 354,739 291,674 288,185
P/E ratio 41.9 x 74.2 x 48.6 x 39.3 x
Yield - 0.25% 0.3% 0.37%
Capitalization / Revenue 5.25 x 10.8 x 7.86 x 6.59 x
EV / Revenue 5.25 x 10.8 x 7.61 x 6.3 x
EV / EBITDA 23.1 x 44.4 x 28.9 x 23.6 x
EV / FCF 34.6 x 107 x 89.7 x 57.6 x
FCF Yield 2.89% 0.93% 1.12% 1.74%
Price to Book 5.82 x 10.4 x 8.55 x 7.15 x
Nbr of stocks (in thousands) 268,195 268,507 - -
Reference price 2 527.0 1,122 1,122 1,122
Announcement Date 5/27/23 5/17/24 - -
1INR in Million2INR
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: March 2022 2023 2024 2025 2026
Net sales 1 - 26,942 32,751 38,348 45,746
EBITDA 1 - 6,122 7,991 10,096 12,191
EBIT 1 - 4,623 6,263 8,405 10,363
Operating Margin - 17.16% 19.12% 21.92% 22.65%
Earnings before Tax (EBT) 1 - 4,493 6,271 8,431 10,299
Net income 1 1,962 3,261 4,782 6,154 7,619
Net margin - 12.1% 14.6% 16.05% 16.66%
EPS 2 7.770 12.57 17.80 23.09 28.59
Free Cash Flow 1 - 4,085 2,751 3,253 5,006
FCF margin - 15.16% 8.2% 8.48% 10.94%
FCF Conversion (EBITDA) - 66.73% 32.32% 32.22% 41.07%
FCF Conversion (Net income) - 125.29% 55.82% 52.85% 65.71%
Dividend per Share 2 - - 2.800 3.350 4.150
Announcement Date 5/26/22 5/27/23 5/17/24 - -
1INR in Million2INR
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: March 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 7,034 7,730 7,997 8,141 8,513
EBITDA 1 1,631 1,843 1,908 2,030 2,207
EBIT 1 1,252 1,439 1,510 1,650 1,728
Operating Margin 17.79% 18.62% 18.88% 20.27% 20.3%
Earnings before Tax (EBT) 1 1,331 1,410 1,537 1,634 1,863
Net income 1 1,011 1,020 1,094 1,173 1,304
Net margin 14.37% 13.2% 13.69% 14.41% 15.32%
EPS 2 3.760 3.800 4.100 4.300 4.600
Dividend per Share - - - - -
Announcement Date 5/27/23 8/10/23 - - -
1INR in Million2INR
Estimates

Balance Sheet Analysis

Fiscal Period: March 2022 2023 2024 2025 2026
Net Debt 1 - - - - -
Net Cash position 1 - - 7,080 9,699 13,187
Leverage (Debt/EBITDA) - - - - -
Free Cash Flow 1 - 4,085 2,751 3,253 5,006
ROE (net income / shareholders' equity) - 16.1% 18.6% 19.2% 19.7%
ROA (Net income/ Total Assets) - 8.98% 11.7% 13% 13.5%
Assets 1 - 36,307 42,153 47,245 56,362
Book Value Per Share 2 - 90.50 108.0 131.0 157.0
Cash Flow per Share - - - - -
Capex 1 - 2,360 4,457 4,632 4,635
Capex / Sales - 8.76% 13.29% 12.08% 10.13%
Announcement Date 5/26/22 5/27/23 5/17/24 - -
1INR in Million2INR
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
10
Last Close Price
1,122 INR
Average target price
1,376 INR
Spread / Average Target
+22.60%
Consensus
  1. Stock Market
  2. Equities
  3. MEDANTA Stock
  4. Financials Global Health Limited